Market Cap

Leviathan Cannabis Group, Inc. Market Capitalization:

C$19.4 Million

CAD as of Jan. 1, 2026

US$14.2 Million

business Leviathan Cannabis Group, Inc. Company Profile

Leviathan Cannabis Group, Inc. Main Stock Listing

CSE: EPIC

Market Capitalization History of Leviathan Cannabis Group, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Leviathan Cannabis Group, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 C$19.4 M -34.00%
Jan. 1, 2025 C$29.4 M -82.76%
Jan. 1, 2024 C$170.7 M -9.56%
Jan. 1, 2023 C$188.8 M 146.27%
Jan. 1, 2022 C$76.7 M 63.41%
Jan. 1, 2021 C$46.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Leviathan Cannabis Group, Inc. Categories

Canada languages Healthcare languages Drug Manufacturers—Specialty & Generic
Canada Healthcare Canada Drug Manufacturers—Specialty & Generic

Stocks & Indices

Leviathan Cannabis Group, Inc. has the following listings and related stock indices.


Stock: CSE: EPIC

Stock: OTC: LVCNF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.